LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of two important products to support the fight against COVID-19: - a CE-IVD labelled rapid test ...
LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News: Eurofins (Paris:ERF) U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price ...
FRAMINGHAM, Mass., Dec. 16, 2020 /PRNewswire/ -- Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being offered in all 50 states. Previously, the At-Home test was not ...
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins’s (Paris:ERF) Clinical Enterprise, Inc. announces that it has received US Food and Drug Administration Emergency Use Authorization (EUA) for a ...
LEE'S SUMMIT, Mo., July 29, 2020 /PRNewswire/ -- Eurofins U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price per PCR ...
The Chagas (T. cruzi) qPCR test is a crucial tool for the accurate detection of Trypanosoma cruzi infection, a disease that often goes undiagnosed due to its asymptomatic nature in its early stages. A ...
LENEXA, Kan., May 28, 2025 /PRNewswire/ -- Eurofins Viracor announced today the launch of its new quantitative real-time PCR assays for dimorphic fungi, a significant advancement in the rapid and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback